Phase 1 clinical study of an embryonic stem cell – derived retinal pigment epithelium patch in age-related macular degeneration
Nature Biotechnology 36, 328 (2018).
doi:10.1038/nbt.4114
Authors: Lyndon da Cruz, Kate Fynes, Odysseas Georgiadis, Julie Kerby, Yvonne H Luo, Ahmad Ahmado, Amanda Vernon, Julie T Daniels, Britta Nommiste, Shazeen M Hasan, Sakina B Gooljar, Amanda-Jayne F Carr, Anthony Vugler, Conor M Ramsden, Magda Bictash, Mike Fenster, Juliette Steer, Tricia Harbinson, Anna Wilbrey, Adnan Tufail, Gang Feng, Mark Whitlock, Anthony G Robson, Graham E Holder, Mandeep S Sagoo, Peter T Loudon, Paul Whiting & Peter J Coffey
Source: Nature Biotechnology - Category: Biotechnology Authors: Lyndon da Cruz Kate Fynes Odysseas Georgiadis Julie Kerby Yvonne H Luo Ahmad Ahmado Amanda Vernon Julie T Daniels Britta Nommiste Shazeen M Hasan Sakina B Gooljar Amanda-Jayne F Carr Anthony Vugler Conor M Ramsden Magda Bictash Mike Fenster Juliette Steer Tags: Research Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Biotechnology | Stem Cell Therapy | Stem Cells | Study | Vitamin A